Drugmakers developing monthly weight loss drugs rather than weekly
01:59
New Report Sheds Light on How Kids Are Using AI
04:19
Patients Compare Using AI Versus Doctors for Medical Advice
05:05
Simone Biles Reveals Health Scare, Near-Death Experience
01:57
Former NYPD detectives speak out about Luigi Mangione manhunt for first time
02:06
Measles cases on the rise since the start of the year
02:26
A to Zzzz Guide for Getting Better Sleep in Summer
03:57
Boost Your Gut-Brain Connection With These Smart Strategies
05:45
Surprising Symptoms of Perimenopause: What You Need to Know
06:19
Graduation surprise from doctor of teen who battled stage four cancer
01:21
Dr. Oz says Trump goes for frequent checkups because he 'likes the results'
00:30
How to Advocate for Yourself at the Doctor's Office
04:55
Protests erupt over U.S. Ebola quarantine center in Kenya
01:01
Breakthrough treatment for pancreatic cancer
02:02
Kick Off Summer 2026 Strong With Start TODAY’s Strength Plan
04:43
Get an Inside Look at the 2026 'Big Slick' Charity Weekend
05:03
New Pancreatic Cancer Drug Doubles Survival Rate in Trials
02:02
Hospitals in Brazil Test Two Patients With Ebola-Like Symptoms
02:01
TODAY’s Angie Lassman Checks in After Rupturing Her Achilles
03:16
Top W.H.O. official in Ebola epicenter as deadly outbreak spreads
01:44
Nightly News
FDA approves first medical treatment for Alzheimer’s in 18 years
This version of Fda Approves First Medical Treatment For Alzheimer S In 18 Years 114445381880 - Breaking News | NBC News Clone was adapted by NBC News Clone to help readers digest key facts more efficiently.
01:30
Copied
The drug aducanumab, developed by the company Biogen, attacks the amyloid protein that builds up in the brain of Alzheimer’s patients. The drug is going on the market even though the FDA says there are “uncertainties regarding clinical benefits” and is requiring Biogen to do another clinical trial.June 7, 2021
